21 May 2021
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.
We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free.
Driving convenience; our ultra-short course treatments make life easier and increase adherence. Our adjuvant technologies not only advance the results of allergy immunotherapy but also drive beneficial immune responses in cancer and infectious disease.
We are a proud and passionate team of scientists and business specialists with a vision that delivers growth and transforms the way we think about immunology.
No comments:
Post a Comment